Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 1Phase 1/2 1

Status

Completed 100Recruiting 62Unknown 37Not yet recruiting 21Active not recruiting 20Terminated 15Withdrawn 14Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 13Brain Neoplasms 9Prostatic Neoplasms 7Neoplasms 7Head and Neck Neoplasms 6Motor Activity 4Glioma 4Glioblastoma 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Colorectal Neoplasms 3Quality of Life 2Papillomavirus Infections 2Pancreatic Neoplasms 2Obesity 2Multiple Myeloma 2Melanoma 2Lymphoma, Follicular 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Cancer Pain 2Biliary Tract Neoplasms 2Behavior 2Weight Loss 1Venous Thromboembolism 1Ureteral Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Suspended × Hematologic Neoplasms × Clear all
NCT07285668 2026-04-03

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

University of Wisconsin, Madison

Phase NA Suspended
38 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡